Medical Developments International Limited (ASX:MVP)

Market Cap	54.08M
Revenue (ttm)	39.06M +17.8%
Net Income	94.00K
EPS	0.00
Shares Out	112.66M
PE Ratio	575.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	194,922
Average Volume	76,413
Open	0.4800
Previous Close	0.4800
Day's Range	0.4550 - 0.5150
52-Week Range	0.4200 - 0.9400
Beta	1.50
RSI	34.41
Earnings Date	Feb 18, 2026

About ASX:MVP

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow mete...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MVP